secwatch.observer — SEC 8-K summary
======================================

Issuer:     RAPID MICRO BIOSYSTEMS, INC. (RPID)
CIK:        0001380106
Form:       8-K
Filed at:   2023-11-03T23:59:59+00:00
Accession:  0001380106-23-000173
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rapid Micro Biosystems Q3 revenue $6.1M (+30% YoY); reaffirms FY23 guidance at least $22M
--------------------------------------------------------------------------------

- Q3 revenue $6.1M, up 30% YoY; placed 5 Growth Direct systems, validated 4.
- Net loss $13.4M ($0.31 EPS) vs $16.3M ($0.38) in Q3 2022; loss narrowed.
- Recurring revenue $3.4M (+17%); cash $104M, no debt, runway into 2026.
- Reaffirms FY23 revenue at least $22M (~30% growth) and at least 15 system placements.
- Added a new top 5 global pharma customer; now serves two-thirds of top 20.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1380106/000138010623000173/0001380106-23-000173-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1380106/000138010623000173/rpid-20231103.htm
  HTML page:      https://secwatch.observer/filing/0001380106-23-000173

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer